Results 11 to 20 of about 23,252 (243)
Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide
International Journal of Nephrology and Renovascular Disease, 2016 Valeria Cernaro, Domenico Santoro, Antonio Lacquaniti, Giuseppe Costantino, Luca Visconti, Antoine Buemi, Michele Buemi Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy Abstract: Chronic kidney disease-mineral bone ...
Cernaro V +6 more
doaj +4 more sources
Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice? [PDF]
BMC Nephrology, 2011 Background Aluminium-containing phosphate binders have long been used for treatment of hyperphosphatemia in dialysis patients. Their safety became controversial in the early 1980's after reports of aluminium related neurological and bone disease began to
van Eps Carolyn L +6 more
doaj +2 more sources
Phosphate binders in dialysis: better satisfied than sorry. [PDF]
Clin Kidney J, 2021 High serum phosphate levels have been associated with increased morbidity and mortality in dialysis patients. Nephrologists routinely counteract the positive phosphate balance in dialysis patients through nutritional counselling, stronger phosphate ...
Cozzolino M, Galassi A, Ciceri P.
europepmc +2 more sources
Phosphate Binders and Nonphosphate Effects in the Gastrointestinal Tract. [PDF]
J Ren Nutr, 2020 Phosphate binders are commonly prescribed in patients with end-stage kidney disease to prevent and treat hyperphosphatemia. These binders are usually associated with gastrointestinal distress, may bind molecules other than phosphate, and may alter the ...
Biruete A +5 more
europepmc +2 more sources
Managing Phosphate Burden in Patients Receiving Dialysis: Beyond Phosphate Binders and Diet. [PDF]
Kidney360, 2023 Most patients receiving dialysis rely on dietary restriction and phosphate binders to minimize the risk of hyperphosphatemia, which is associated with increased mortality. However, dietary restriction is difficult because of hidden phosphate additives in
Kalantar-Zadeh K +5 more
europepmc +2 more sources
Do we need new phosphate binders in dialysis? [PDF]
Clin Kidney J, 2021 Patients affected by chronic kidney disease (CKD) have a greater risk of mortality than the general population. Fatalcardiovascular events are the most frequent cause of death in CKD patients, especially in the late stages of disease.Derangement of ...
Cozzolino M, Galassi A, Ciceri P.
europepmc +2 more sources
International Journal of Nephrology and Renovascular Disease, 2013 Adamasco Cupisti,1 Maurizio Gallieni,2 Maria Antonietta Rizzo,2 Stefania Caria,3 Mario Meola,4 Piergiorgio Bolasco31Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 2Nephrology and Dialysis Unit, San Carlo Borromeo ...
Cupisti A +5 more
doaj +2 more sources
Phosphate binders in patients with chronic kidney disease. [PDF]
Aust Prescr, 2017 Hyperphosphataemia in patients with chronic kidney disease, particularly those on dialysis, can be ameliorated by oral phosphate binders in conjunction with dietary phosphate restriction.
Chan S +5 more
europepmc +2 more sources
In Search of an Efficient Complexing Agent for Oxalates and Phosphates: A Quantum Chemical Study
Nanomaterials, 2021 Limiting gastrointestinal oxalate absorption is a promising approach to reduce urinary oxalate excretion in patients with idiopathic and enteric hyperoxaluria.
Jelle Vekeman +9 more
doaj +1 more source
Tailored synbiotic powder (functional food) to prevent hyperphosphataemia (kidney disorder)
Scientific Reports, 2021 Hyperphosphataemia is treated with phosphate binders, which can cause adverse effects. Spray-dried synbiotic powder (SP) composed of Lactobacillus casei JCM1134 (a phosphate-accumulating organism; PAO) and Aloe vera is potentially a safer alternative for
Ajeeta Anand +2 more
doaj +1 more source